epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement
SAGAMIHARA, Japan, Nov. 17, 2023 /PRNewswire/ — epitoMAP Inc. (hereinafter “epitoMAP”) and Animal Allergy Clinical Laboratories Inc. (hereinafter “AACL”) entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd. (hereinafter “ZENOAQ”) on November 10, 2023. Logos:epitoMAP: https://kyodonewsprwire.jp/img/202311132696-O3-B5f8qrzLZENOAQ: https://kyodonewsprwire.jp/img/202311132696-O5-QZ0646h5AACL: https://kyodonewsprwire.jp/img/202311132696-O4-Hw5TKcKs Photos:https://cdn.kyodonewsprwire.jp/prwfile/release/M107929/202311132696/_prw_PI1fl_CUg5pN38.jpg https://cdn.kyodonewsprwire.jp/prwfile/release/M107929/202311132696/_prw_PI2fl_2gLRsvyi.jpg Under the terms of the Agreement, […]